FDA
FDA
05/29/2020
The FDA has granted a landmark approval to an intravenous injection for the imaging of tau pathology among patients with cognitive impairment being evaluated for Alzheimer disease.
05/29/2020
FDA
FDA
05/29/2020
The FDA has granted a landmark approval to an intravenous injection for the imaging of tau pathology among patients with cognitive impairment being evaluated for Alzheimer disease.
05/29/2020
Stress and Burnout
Stress and Burnout
05/28/2020
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized...
05/28/2020
Stress and Burnout
Stress and Burnout
05/28/2020
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized...
05/28/2020
Stress and Burnout
Stress and Burnout
05/28/2020
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized...
05/28/2020
Stress and Burnout
Stress and Burnout
05/28/2020
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized...
05/28/2020
Stress and Burnout
Stress and Burnout
05/28/2020
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized...
05/28/2020
Stress and Burnout
Stress and Burnout
05/28/2020
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized...
05/28/2020
Malaria
Malaria
05/27/2020
Prior to its approval, this treatment for severe malaria was only available through the FDA’s Expanded Access program.
05/27/2020
COVID-19
COVID-19
05/11/2020
This roundup of COVID-19 news includes results of a phase 2 trial of an antiviral triple therapy, the first antigen test authorized by the FDA, pneumonia guidelines, COVID-19–related illness in children,...
05/11/2020